Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Biallelic variants in ADARB1, encoding a dsRNA-specific adenosine deaminase, cause a severe developmental and epileptic encephalopathy

R. Maroofian, J. Sedmík, N. Mazaheri, M. Scala, MS. Zaki, LP. Keegan, R. Azizimalamiri, M. Issa, G. Shariati, A. Sedaghat, C. Beetz, P. Bauer, H. Galehdari, MA. O'Connell, H. Houlden

. 2021 ; 58 (7) : 495-504. [pub] 20200727

Jazyk angličtina Země Velká Británie

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012367

Grantová podpora
Wellcome Trust - United Kingdom
MR/S01165X/1 Medical Research Council - United Kingdom
MR/S005021/1 Medical Research Council - United Kingdom
WT093205MA Wellcome Trust - United Kingdom
WT104033AIA Wellcome Trust - United Kingdom

E-zdroje Online Plný text

NLK ProQuest Central od 1994-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 1994-01-01 do Před 6 měsíci

BACKGROUND: Adenosine-to-inosine RNA editing is a co-transcriptional/post-transcriptional modification of double-stranded RNA, catalysed by one of two active adenosine deaminases acting on RNA (ADARs), ADAR1 and ADAR2. ADARB1 encodes the enzyme ADAR2 that is highly expressed in the brain and essential to modulate the function of glutamate and serotonin receptors. Impaired ADAR2 editing causes early onset progressive epilepsy and premature death in mice. In humans, ADAR2 dysfunction has been very recently linked to a neurodevelopmental disorder with microcephaly and epilepsy in four unrelated subjects. METHODS: We studied three children from two consanguineous families with severe developmental and epileptic encephalopathy (DEE) through detailed physical and instrumental examinations. Exome sequencing (ES) was used to identify ADARB1 mutations as the underlying genetic cause and in vitro assays with transiently transfected cells were performed to ascertain the impact on ADAR2 enzymatic activity and splicing. RESULTS: All patients showed global developmental delay, intractable early infantile-onset seizures, microcephaly, severe-to-profound intellectual disability, axial hypotonia and progressive appendicular spasticity. ES revealed the novel missense c.1889G>A, p.(Arg630Gln) and deletion c.1245_1247+1 del, p.(Leu415PhefsTer14) variants in ADARB1 (NM_015833.4). The p.(Leu415PhefsTer14) variant leads to incorrect splicing resulting in frameshift with a premature stop codon and loss of enzyme function. In vitro RNA editing assays showed that the p.(Arg630Gln) variant resulted in a severe impairment of ADAR2 enzymatic activity. CONCLUSION: In conclusion, these data support the pathogenic role of biallelic ADARB1 variants as the cause of a distinctive form of DEE, reinforcing the importance of RNA editing in brain function and development.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012367
003      
CZ-PrNML
005      
20220506130034.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/jmedgenet-2020-107048 $2 doi
035    __
$a (PubMed)32719099
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Maroofian, Reza $u Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK
245    10
$a Biallelic variants in ADARB1, encoding a dsRNA-specific adenosine deaminase, cause a severe developmental and epileptic encephalopathy / $c R. Maroofian, J. Sedmík, N. Mazaheri, M. Scala, MS. Zaki, LP. Keegan, R. Azizimalamiri, M. Issa, G. Shariati, A. Sedaghat, C. Beetz, P. Bauer, H. Galehdari, MA. O'Connell, H. Houlden
520    9_
$a BACKGROUND: Adenosine-to-inosine RNA editing is a co-transcriptional/post-transcriptional modification of double-stranded RNA, catalysed by one of two active adenosine deaminases acting on RNA (ADARs), ADAR1 and ADAR2. ADARB1 encodes the enzyme ADAR2 that is highly expressed in the brain and essential to modulate the function of glutamate and serotonin receptors. Impaired ADAR2 editing causes early onset progressive epilepsy and premature death in mice. In humans, ADAR2 dysfunction has been very recently linked to a neurodevelopmental disorder with microcephaly and epilepsy in four unrelated subjects. METHODS: We studied three children from two consanguineous families with severe developmental and epileptic encephalopathy (DEE) through detailed physical and instrumental examinations. Exome sequencing (ES) was used to identify ADARB1 mutations as the underlying genetic cause and in vitro assays with transiently transfected cells were performed to ascertain the impact on ADAR2 enzymatic activity and splicing. RESULTS: All patients showed global developmental delay, intractable early infantile-onset seizures, microcephaly, severe-to-profound intellectual disability, axial hypotonia and progressive appendicular spasticity. ES revealed the novel missense c.1889G>A, p.(Arg630Gln) and deletion c.1245_1247+1 del, p.(Leu415PhefsTer14) variants in ADARB1 (NM_015833.4). The p.(Leu415PhefsTer14) variant leads to incorrect splicing resulting in frameshift with a premature stop codon and loss of enzyme function. In vitro RNA editing assays showed that the p.(Arg630Gln) variant resulted in a severe impairment of ADAR2 enzymatic activity. CONCLUSION: In conclusion, these data support the pathogenic role of biallelic ADARB1 variants as the cause of a distinctive form of DEE, reinforcing the importance of RNA editing in brain function and development.
650    _2
$a adenosindeaminasa $x genetika $x metabolismus $7 D000243
650    _2
$a alely $7 D000483
650    _2
$a nemoci mozku $x enzymologie $x genetika $x metabolismus $7 D001927
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a pokrevní příbuzenství $7 D003241
650    _2
$a epilepsie $x enzymologie $x genetika $7 D004827
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a mutace $7 D009154
650    _2
$a neurovývojové poruchy $x enzymologie $x genetika $7 D065886
650    _2
$a rodokmen $7 D010375
650    _2
$a editace RNA $7 D017393
650    _2
$a dvouvláknová RNA $x metabolismus $7 D012330
650    _2
$a proteiny vázající RNA $x genetika $x metabolismus $7 D016601
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sedmík, Jiří $u CEITEC, Masaryk University, Kamenice 735/5, A35, Brno 62500, Czech Republic
700    1_
$a Mazaheri, Neda $u Department of Genetics, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran
700    1_
$a Scala, Marcello $u Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK $u Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università degli Studi di Genova, Genova, Italy $1 https://orcid.org/0000000321947239
700    1_
$a Zaki, Maha S $u Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt
700    1_
$a Keegan, Liam P $u CEITEC, Masaryk University, Kamenice 735/5, A35, Brno 62500, Czech Republic
700    1_
$a Azizimalamiri, Reza $u Department of Paediatric Neurology, Golestan, Medical, Educational, and Research Center, Ahvaz Jundishapur University of Medical Sciences, Behbahan, Iran
700    1_
$a Issa, Mahmoud $u Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt $1 https://orcid.org/0000000238992821
700    1_
$a Shariati, Gholamreza $u Department of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Behbahan, Iran
700    1_
$a Sedaghat, Alireza $u Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of medical Sciences, Ahvaz, Iran
700    1_
$a Beetz, Christian $u CENTOGENE AG, Rostock, Germany $1 https://orcid.org/0000000170612895
700    1_
$a Bauer, Peter $u CENTOGENE AG, Rostock, Germany
700    1_
$a Galehdari, Hamid $u Department of Genetics, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran
700    1_
$a O'Connell, Mary A $u CEITEC, Masaryk University, Kamenice 735/5, A35, Brno 62500, Czech Republic h.houlden@ucl.ac.uk mary.oconnell@ceitec.muni.cz
700    1_
$a Houlden, Henry $u Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK h.houlden@ucl.ac.uk mary.oconnell@ceitec.muni.cz
773    0_
$w MED00002790 $t Journal of medical genetics $x 1468-6244 $g Roč. 58, č. 7 (2021), s. 495-504
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32719099 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130026 $b ABA008
999    __
$a ok $b bmc $g 1789803 $s 1163568
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 58 $c 7 $d 495-504 $e 20200727 $i 1468-6244 $m Journal of medical genetics $n J Med Genet $x MED00002790
GRA    __
$p Wellcome Trust $2 United Kingdom
GRA    __
$a MR/S01165X/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a MR/S005021/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a WT093205MA $p Wellcome Trust $2 United Kingdom
GRA    __
$a WT104033AIA $p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...